GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of dose escalation: the version I wish someone had shown me in week 1 — 56 comments in the full submission. View in context.
6k
c/retatrutide·submitted 1 year ago by u/trialwatch_theo

dose escalation: the version I wish someone had shown me in week 1

Discussionbranch of 6 comments

Confession thread, sort of. I went from 5mg to 1.7mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 10 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have…

Read the full submission and all 56 comments →

This branch

6 comments, started 1 year ago
u/iman_castellanos394 points·1 year ago·edited

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

replysharereportpermalink
u/tired_ledger_notes101 points·1 year ago·edited

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/nikhil_asante84 points·1 year ago

Are you quoting phase 2 or is there phase 3 data now?

replysharereportpermalink
u/yannick_barros80 points·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/trialwatch_theoOPtrial nerd60 points·1 year ago

The glucagon component does different things than dual agonism. The injection-site soreness are not just amplified versions.

replysharereportpermalink
u/cold_chromatogram_only37 points·1 year ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.